[Agammaglobulinemia with the absence of circulating B-lymphocytes. 9 cases]. 1998

M Bejaoui, and M R Barbouche, and F Mellouli, and N Tirellil, and K Dellagi
Centre National de Greffe de Moelle osseuse, Tunis, Tunisie.

OBJECTIVE Agammaglobulinemia with absence of circulating B lymphocytes is a rare genetically transmitted immunodeficiency that appears in early childhood and affect mainly boys. The clinical manifestations of the disease are rather heterogeneous. METHODS Nine patients (7 boys and 2 girls) were diagnosed as suffering from agammaglobulinemia with absence of circulating B lymphocytes, over a period of 6 years. Quantitation of immunoglobulins and search for circulating B lymphocytes were respectively performed by the Mancini method and immunofluorescence using T specific (anti-CD3, anti-CD4 and anti-CD8) and B (anti-CD19) monoclonal antibody. RESULTS The disease started to manifest clinically at the mean age of 8.7 months (4-16 months). The mean age at diagnosis is 4 years (1-11 years). The clinical manifestations were essentially recurrent infections of the lung and the gastrointestinal tract. However, bacterial meningitidis was observed in 3 patients. Severe complications such as an echovirus 27 meningoencephalitis and a chronic active hepatitis (1 patient) and a pericarditis (1 patient) were observed. All of our patients lacked circulating B lymphocytes and had low or null immunoglobulin levels. Five patients were treated by intravenous immunoglobulin (Ig) and 3 were treated by intramuscular immunoglobulin with a residual IgG level respectively of 5.5 g/l and 3.3 g/l. CONCLUSIONS Recurrent infections are the principal manifestation of the agammaglobulinemia, early Ig treatment is the only therapy allowing improved.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007223 Infant A child between 1 and 23 months of age. Infants
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D008231 Lymphopenia Reduction in the number of lymphocytes. Lymphocytopenia,Lymphocytopenias,Lymphopenias
D008297 Male Males
D008590 Meningoencephalitis An inflammatory process involving the brain (ENCEPHALITIS) and meninges (MENINGITIS), most often produced by pathogenic organisms which invade the central nervous system, and occasionally by toxins, autoimmune disorders, and other conditions. Cerebromeningitis,Encephalomeningitis,Cerebromeningitides,Encephalomeningitides,Meningoencephalitides
D009894 Opportunistic Infections An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression. Infection, Opportunistic,Infections, Opportunistic,Opportunistic Infection

Related Publications

M Bejaoui, and M R Barbouche, and F Mellouli, and N Tirellil, and K Dellagi
March 1976, Clinical immunology and immunopathology,
M Bejaoui, and M R Barbouche, and F Mellouli, and N Tirellil, and K Dellagi
January 1977, Pathologica,
M Bejaoui, and M R Barbouche, and F Mellouli, and N Tirellil, and K Dellagi
September 1978, Indian pediatrics,
M Bejaoui, and M R Barbouche, and F Mellouli, and N Tirellil, and K Dellagi
August 1974, American journal of diseases of children (1960),
M Bejaoui, and M R Barbouche, and F Mellouli, and N Tirellil, and K Dellagi
October 1977, Journal of immunology (Baltimore, Md. : 1950),
M Bejaoui, and M R Barbouche, and F Mellouli, and N Tirellil, and K Dellagi
January 1977, Le Poumon et le coeur,
M Bejaoui, and M R Barbouche, and F Mellouli, and N Tirellil, and K Dellagi
May 1977, Minerva pediatrica,
M Bejaoui, and M R Barbouche, and F Mellouli, and N Tirellil, and K Dellagi
December 1977, Minerva pediatrica,
M Bejaoui, and M R Barbouche, and F Mellouli, and N Tirellil, and K Dellagi
March 2008, Arthritis and rheumatism,
M Bejaoui, and M R Barbouche, and F Mellouli, and N Tirellil, and K Dellagi
October 2014, The Journal of allergy and clinical immunology,
Copied contents to your clipboard!